Myeloma bone disease

This publication has 91 references indexed in Scilit:

• Urinary N-telopeptide levels in multiple myeloma patients, correlation with Tc-99m-sestaMIBI scintigraphy and other biochemical markers of disease activity
  Hematological Oncology, 2002
• Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
  New England Journal of Medicine, 1999
• Monitoring the action of clodronate with type I collagen metabolites in multiple myeloma
  European Journal Of Cancer, 1996
• MR appearance of multiple myeloma of the spine before and after treatment.
  American Journal of Roentgenology, 1993
• Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR imaging.
  American Journal of Roentgenology, 1993
• Prospective randomised study of double hemi-body irradiation with and without subsequent maintenance recombinant alpha 2b interferon on survival in patients with relapsed multiple myeloma
  European Journal Of Cancer, 1992
• Treatment of bone metastases from breast cancer and myeloma with pamidronate
  European Journal of Cancer and Clinical Oncology, 1991
• Use of pamidronate for multiple myeloma osteolytic lesions
  The Lancet, 1990
• The prognostic significance of X‐ray changes at presentation and reassessment in patients with multiple myeloma
  Hematological Oncology, 1988
• Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple Myeloma
  Metabolic Bone Disease and Related Research, 1982